Remedium Bio, Inc. is a preclinical-stage biotechnology company developing novel gene therapies for a broad range of highly debilitating diseases. The company's R&D approach focuses on modularly combining proven technologies to treat well-characterized disease pathology streamlining elements of the product development process.
Market
Gene Therapy
Location
Needham,
MA,
USA
Coinvestors
Star Ventures, Apis Health Angels, Guindy Alumni Angels, Longevitytech.fund, MicroVentures, Primo Medical Group, Sherwood Ventures